STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 71 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $179,000 | -33.5% | 87,885 | -3.1% | 0.00% | – |
| Q2 2021 | $269,000 | -79.2% | 90,742 | -80.6% | 0.00% | – |
| Q1 2021 | $1,292,000 | +11.2% | 468,103 | -2.1% | 0.00% | – |
| Q4 2020 | $1,162,000 | +33.0% | 478,253 | +15.0% | 0.00% | – |
| Q3 2020 | $874,000 | -46.4% | 415,964 | -3.6% | 0.00% | – |
| Q2 2020 | $1,631,000 | +112.9% | 431,706 | +6.7% | 0.00% | – |
| Q1 2020 | $766,000 | -7.4% | 404,784 | +2.4% | 0.00% | – |
| Q4 2019 | $827,000 | +3.1% | 395,460 | +17.9% | 0.00% | – |
| Q3 2019 | $802,000 | +735.4% | 335,384 | +989.9% | 0.00% | – |
| Q2 2019 | $96,000 | -95.4% | 30,771 | -87.0% | 0.00% | -100.0% |
| Q1 2018 | $2,098,000 | +26.5% | 237,053 | +3.6% | 0.00% | – |
| Q4 2017 | $1,659,000 | +17.6% | 228,841 | +11.9% | 0.00% | – |
| Q3 2017 | $1,411,000 | -3.5% | 204,560 | +0.0% | 0.00% | – |
| Q2 2017 | $1,462,000 | – | 204,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |